Genomic research is at risk from ‘race science’ activists’ discredited ideas
By Bill Newman and Demetra Georgiou,
The Guardian
| 11. 03. 2024
We were alarmed to read the findings of your investigation into an international network of “race science” activists seeking to influence public debate with discredited ideas on race and eugenics (Revealed: International ‘race science’ network secretly funded by US tech boss, 16 October).
As organisations representing leading researchers and clinicians working in human genetics, we can state unequivocally that race is a fluid social, historical and political construct with no biological or genetic basis. There is convincing evidence that there is more genetic variation within self-identified racial groups than there is between them. It is also widely recognised that the eugenics movement of the late 19th and early 20th centuries was not based on scientific evidence, as set out recently by the Royal College of Physicians in a statement on the history of the UK’s eugenics movement.
We firmly believe that equality, equity, diversity, inclusion and respect for data privacy are central to improving healthcare through research. We recognise that it may not always be possible to prevent malicious actors from hacking datasets and databases and from making...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...